You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Eczema

Tacrolimus and pimecrolimus for atopic eczema

  • Technology appraisal guidance
  • Reference number: TA82
  • Published:  25 August 2004
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Clinical need and practice
  • 3 The technologies
  • 4 Evidence and interpretation
  • 5 Recommendations for further research
  • 6 Implications for the NHS
  • 7 Implementation and audit
  • 8 Appraisal Committee members and NICE project team
  • 9 Sources of evidence considered by the Committee
  • Appendix A Detail on criteria for audit of the use of tacrolimus and pimecrolimus for atopic eczema
  • Update information

Update information

March 2014: Implementation section updated to clarify that tacrolimus and pimecrolimus are recommended as options for treating atopic eczema.

ISBN: 978-1-4731-7000-1


Previous page Appendix A Detail on criteria for audit of the use of tacrolimus and pimecrolimus for atopic eczema
Back to top